Search research articles
Contact Us
Filters
Showing results (151-160 of 205) with videos related to
Page
of 21
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
May 4, 2026
Item generation for a new disease-specific health-related quality of life questionnaire in patients with deep vein thrombosis: an international multicenter study
Elia Asady, Lars-Petter Jelsness-Jorgensen, Waleed Ghanima, et al.
Blood
|
August 20, 2020
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
Marc Michel, Marco Ruggeri, Tomas Jose Gonzalez-Lopez, et al.
British Journal of Haematology
|
June 19, 2024
Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia
Maria Eva Mingot-Castellano, Jose Maria Bastida, Waleed Ghanima, et al.
Therapeutic Advances in Hematology
|
October 23, 2023
Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
David J Kuter, James B Bussel, Waleed Ghanima, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
July 10, 2021
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
Sigrun Halvorsen, Søren P Johnsen, Morten Madsen, et al.
American Heart Journal
|
October 31, 2007
Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)
Tone Enden, Leiv Sandvik, Nils-Einar Kløw, et al.
Thrombosis Research
|
December 6, 2019
Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists
Lamya Garabet, Carola E Henriksson, María Luisa Lozano, et al.
BMC Health Services Research
|
October 1, 2017
Evaluating patient experiences in decentralised acute care using the Picker Patient Experience Questionnaire; methodological and clinical findings
Ann-Chatrin Linqvist Leonardsen, Vigdis Abrahamsen Grøndahl, Waleed Ghanima, et al.
Platelets
|
December 8, 2017
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia
Lamya Garabet, Waleed Ghanima, Christine Monceyron Jonassen, et al.
Lancet (London, England)
|
December 17, 2011
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
Tone Enden, Ylva Haig, Nils-Einar Kløw, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 205) with videos related to
Sort By:
Page
of 21
Research and Practice in Thrombosis and Haemostasis
|
May 4, 2026
Item generation for a new disease-specific health-related quality of life questionnaire in patients with deep vein thrombosis: an international multicenter study
Elia Asady, Lars-Petter Jelsness-Jorgensen, Waleed Ghanima, et al.
Blood
|
August 20, 2020
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
Marc Michel, Marco Ruggeri, Tomas Jose Gonzalez-Lopez, et al.
British Journal of Haematology
|
June 19, 2024
Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia
Maria Eva Mingot-Castellano, Jose Maria Bastida, Waleed Ghanima, et al.
Therapeutic Advances in Hematology
|
October 23, 2023
Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
David J Kuter, James B Bussel, Waleed Ghanima, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
July 10, 2021
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
Sigrun Halvorsen, Søren P Johnsen, Morten Madsen, et al.
American Heart Journal
|
October 31, 2007
Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)
Tone Enden, Leiv Sandvik, Nils-Einar Kløw, et al.
Thrombosis Research
|
December 6, 2019
Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists
Lamya Garabet, Carola E Henriksson, María Luisa Lozano, et al.
BMC Health Services Research
|
October 1, 2017
Evaluating patient experiences in decentralised acute care using the Picker Patient Experience Questionnaire; methodological and clinical findings
Ann-Chatrin Linqvist Leonardsen, Vigdis Abrahamsen Grøndahl, Waleed Ghanima, et al.
Platelets
|
December 8, 2017
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia
Lamya Garabet, Waleed Ghanima, Christine Monceyron Jonassen, et al.
Lancet (London, England)
|
December 17, 2011
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
Tone Enden, Ylva Haig, Nils-Einar Kløw, et al.
Page
of 21